|
J Biol Chem, Vol. 274, Issue 43, 31068-31075, October 22, 1999
Characterization of a Mammalian Gene Related to the Yeast
CCR4 General Transcription Factor and Revealed by Transposon
Insertion*
Anne
Dupressoir,
Willy
Barbot,
Marie-Paule
Loireau, and
Thierry
Heidmann
From the Unité des Rétrovirus Endogènes et
Eléments Rétroïdes des Eucaryotes Supérieurs,
CNRS UMR 1573, Institut Gustave Roussy, 39 rue Camille Desmoulins,
94805 Villejuif Cedex, France
 |
ABSTRACT |
Murine intracisternal A-particles (IAPs) are
reiterated retrovirus-like transposable elements that can act as
insertional mutagens. Accordingly, we previously identified a chimeric
transcript initiated at an IAP promoter and extending through a
3'-located open reading frame with significant similarity to the
C-terminal domain of the yeast CCR4 general transcription factor. In
this report, we characterize the corresponding murine gene,
mCCR4, and its human homologue, thus providing the first
description of CCR4-like factors in mammals. cDNA cloning revealed
two mCCR4 mRNAs of 2.7 and 3.1 kilobases, differing by
their transcription start sites within the native mCCR4
gene promoter, and encoding a putative 430-amino acid protein.
The mCCR4 gene contains three exons and two introns
spanning almost 27 kilobases. The IAP insertion, detected only in some
laboratory mouse strains, is recent and lies within the first intron.
The 5'-region of the gene has features of housekeeping gene promoters.
It lacks a TATA box but contains a CpG island and Sp1 sites. This
region discloses strong promoter activity in transient transfection
assays and also stimulates transcription in the reverse orientation, a
feature common to other CpG island-containing promoters. Transcripts
were detected in all the organs tested, although at a variable level,
and displayed no strain-dependent differences relative to
the IAP insertion, suggesting the existence of mechanisms preserving
mCCR4 transcription from the usually deleterious effects of
intronic transposition. The strong amino acid conservation between the
human, murine, and the previously identified Xenopus
CCR4-like proteins, is consistent with an important and conserved role
for this protein in vertebrates.
 |
INTRODUCTION |
The general transcription factor CCR4 from Saccharomyces
cerevisiae (yCCR4) is required for the transcription of several
nonfermentative genes, including that of the glucose-repressible
alcohol dehydrogenase (1, 2). It is part of a multi-subunit complex,
several components of which have been characterized including DBF2, a
cell cycle-regulated protein kinase (3), and proteins of the NOT
family, involved in repression of transcription (4). yCCR4 displays a
glutamine-rich N terminus, like many factors involved in
transcriptional activation, and a leucine-rich repeat motif that is
necessary for protein-protein interactions within the complex (5, 6).
Both motifs are required for transcriptional activation by yCCR4. The
yCCR4 complex was demonstrated to function at a post-chromatin
remodeling step in the case of the ADH2 gene (7) and to play
an important role in several cellular processes: yCCR4 affects the
expression of genes involved in cell wall integrity (3), in UV
sensitivity (8), and in methionine biosynthesis (9). Although the
mechanism of how yCCR4 functions remains undefined (yet the yCCR4
protein does not bind DNA by itself, Ref. 6), several lines of evidence suggest that the complex plays an important and conserved role in
vertebrate gene regulation as well. Actually, there is increasing evidence for the existence of yCCR4-like proteins in higher eucaryotes. First, a gene encoding a yCCR4-like protein (named nocturnin) has been
identified in Xenopus (10). Nocturnin displays a strong similarity to the C-terminal part of yCCR4 and contains a leucine zipper-like dimerization domain. Interestingly, nocturnin expression discloses a strong circadian regulation in the retina, suggesting that
it could be involved in the circadian clock system. Second, the
existence of yCCR4-like proteins in mammals is strongly supported by
the results of Draper et al. (11). Those authors identified a mouse protein (mCAF1) which can functionally interact, in a yeast
two-hybrid assay, with the yeast yCCR4 factor, thus indicating a strong
evolutionary conservation of at least some components of a
CCR4-containing transcriptional regulatory complex. Finally, our group
identified, at the 3'-end of an intracisternal A-particle chimeric
murine transcript, a 1-kb1
open reading frame (ORF) with significant similarity to the yCCR4 C-terminal domain (12). Intracisternal A-particle (IAP) sequences are
moderately reiterated transposable elements (~1000 copies in the
mouse genome) which are closely related to retroviruses and transpose
via the reverse transcription of an RNA intermediate (13, 14). They are
flanked by two long terminal repeats (LTR), with a U3-R-U5
organization, that contain the signals for the initiation and
regulation of transcription (5'-LTR) and for the polyadenylation of the
transcripts (3'-LTR). IAPs are one of the most potent insertional
mutagens in the mouse, and it is well documented that their insertion
can perturb the normal pattern of expression of the targeted cellular
genes (reviewed in Refs. 13 and 15). In this respect, we had previously
characterized three IAP transcripts of abnormal size (3, 6, and 10 kb,
named IAP-AR transcripts), which are induced exclusively in the liver of old mice (16). We have shown that the 10-kb IAP-AR transcript is
initiated within the 5'-LTR of an IAP gene and corresponds to a
transcriptional read-through extending beyond the 3'-LTR into a
cellular sequence containing the 1-kb ORF with significant similarity
to the yCCR4 C-terminal domain (12). This 10-kb transcript gives rise
to the two smaller transcripts by one or two splicing events using
donor and acceptor sites within the IAP sequence and an acceptor site
5' to the yCCR4-related ORF. We hypothesized that the IAP sequence was
inserted into an intron of a mouse gene related to the yCCR4
gene. As a first step to elucidate the potential role of this factor in
mammals, we have now characterized this gene, tentatively named
mCCR4. We present an analysis of its genomic organization
and of the structure of its associated transcripts. mCCR4
has all the characteristics features of a "housekeeping gene," with
a CpG island-containing promoter and a ubiquitous expression in the
mouse. We further show that the IAP insertion, in the first intron, is
a recent phenomenon, being absent in some laboratory mouse strains. A
comparison of the mCCR4 transcripts in both types of mice
discloses no effect of the IAP insertion on the structure and pattern
of expression of the mCCR4 gene (with the exception of the
liver of aged mice, see above). This rather unusual situation suggests
a strong selective pressure for maintaining mCCR4 function,
a result consistent with the high amino acid conservation found with
the human homologue of mCCR4, which we have also
characterized in the present work, and a central role for these factors
in vertebrates.
 |
EXPERIMENTAL PROCEDURES |
Characterization of Murine and Human yCCR4-related
cDNAs--
Cloning the murine yCCR4-related cDNA was achieved
by 5'- and 3'-rapid amplification of cDNA ends (RACE) using a
Marathon-ReadyTM mouse brain cDNA library
(CLONTECH, constructed from normal whole brains
pooled from 9-11-week old BALB/c males). Primers complementary to the
adaptator sequence and various primers derived from the mCCR4 sequence were used in nested PCR reactions. For exons
2 and 3 of the human yCCR4-related cDNA, we used a
Marathon-ReadyTM human placenta cDNA library
(CLONTECH) and low-stringency PCR reactions (a
first step at 94 °C for 60 s; then 4 cycles at 94 °C for
30 s and 61 °C for 50 s; 4 cycles at 94 °C for 20 s and 59 °C for 50 s; 4 cycles at 94 °C for 20 s and
57 °C for 50 s; 30 cycles at 94 °C for 20 s, 55 °C
for 30 s, and 72 °C for 60 s; and ending with a step at
72 °C for 2 min). Characterization of the 5'-end of the human
cDNA (exon 1 and 5'-UTR) was achieved using an oligo(dT)-primed
human cDNA library2 in
which the cDNAs, prepared from mRNA isolated from NTera2D1 teratocarcinoma cells, are inserted into a retroviral vector. Successive 5'-RACE PCR reactions were performed using primers in the
human sequence and primers in the retroviral vector. All PCR reactions,
except the low-stringency PCRs, were performed using the Advantage-GC
cDNA Polymerase Mix (CLONTECH, specifically designed for GC-rich cDNAs) with a 95 °C denaturation step for 80 s followed by 60 cycles at 95 °C for 20 s, 66 °C for
3 min, and final extension at 66 °C for 10 min. Amplification
products were subcloned into the T-vector (Promega) and sequenced.
Characterization of Genomic DNA--
PCR amplifications with
genomic DNA were performed using the Advantage-GC cDNA Polymerase
Mix or the Advantage-GC Genomic Polymerase Mix (both from
CLONTECH). Mapping of exon-intron boundaries was
achieved by PCR amplification of intronic sequences with primers designed from the cDNA sequences. For large introns, long distance PCR was performed after a 95 °C denaturation step for 2 min, by 60 cycles at 95 °C for 20 s, and 66 °C for 14 min. Final
extension was at 66 °C for 10 min. Inverted PCR amplification was
performed as described in Ref. 14 using genomic DNA first digested by restriction enzymes and then self-ligated, and pairs of primers in
opposite orientation. A mouse 129/sv lambda genomic library (Stratagene) was screened using a PCR-based method (17) with primers
bracketing the exon 1/intron 1 junction. 105 plaque-forming
units were amplified in an XL1-Blue MRA host strain, distributed in
96-well plates, and then subjected to PCR amplification. 200 plaque-forming units of a single positive well were further analyzed
using a conventional plaque hybridization assay, leading to the
isolation of an mCCR4-containing phage.
DNA Isolation and Southern Blot Analysis--
High molecular
weight DNA was extracted from the tail of various inbred strains. Tails
were lysed overnight in 50 mM Tris (pH 8), 10 mM EDTA (pH 8), 100 mM NaCl, 0.2% SDS and 500 µg/ml Proteinase K. DNA was then extracted by phenol-chloroform
treatment and ethanol precipitation. For each restriction analysis, 10 µg of DNA was cleaved with at least a 4-fold excess of restriction enzyme for 10 h, electrophoresed on a 1% agarose gel, and then analyzed by Southern blotting (18). A SpeI-BstXI
fragment (460 bp) isolated from an inverted PCR product containing the
region 5' to the IAP was first used as a probe. After dehybridization, the same blot was then rehybridized with an intronic probe generated by
PCR amplification of mouse genomic DNA using primers AR-B11 and AR-B12
(probe A in Ref. 12).
Assay for Promoter Activity--
The pGL3 expression vector
(Promega) containing the firefly luciferase as a reporter gene was used
to assay the promoter activity of cloned genomic DNA fragments from the
5'-region of the mCCR4 gene. Several fragments were excised
from an inverted PCR product containing the 5'-region of the
mCCR4 gene, blunt-ended, and cloned bidirectionally into the
SmaI site of the pGL3 vector: a
XbaI-BglI fragment, [ 500/+114] pGL3 and
[+114/ 500] pGL3 constructs); a XmaI-BglI
fragment, [ 227/+114] pGL3 and [+114/ 227] pGL3 constructs an
AlwNI-BglI fragment, [ 100/+114] pGL3, and
[+114/ 100] pGL3 constructs; and a DraIII-BglI
fragment ([+4/+114] pGL3 and [+114/+4] pGL3 constructs). The
[BssHII-BglI] pGL3 construct ([ 30/+114] pGL3) was subsequently generated by deleting the
SacI-BssHII fragment from the
[XbaI-BglI] pGL3 vector, and the
[BglI-BssHII] pGL3 construct ([+114/ 30]
pGL3) was obtained by deleting the BssHII-HindIII fragment from the [BglI-XbaI] pGL3 vector. A
basic pGL3 promoterless luciferase vector and an SV40 promoter/enhancer
luciferase vector were used as negative and positive control vectors,
respectively. NIH-3T3 cells were grown in Dulbecco's modified Eagle's
medium containing 10% fetal calf serum and transfected using the
LipofectAMINE PLUSTM Reagent (Life Technologies, Inc.).
Cells (5 ×105) were transfected with 1 ng of luciferase
construct and 1 ng of a -galactosidase gene containing vector
(CMV , Stratagene) as a control for transfection efficacy. Two days
post-transfection, cells were assayed for luciferase using Reporter
Lysis Buffer (Promega) and for -galactosidase using CPRG (Roche
Molecular Biochemicals).
RNA Isolation and Northern Blot Analyses--
Total cellular
RNAs from various tissues were extracted using a pre-packed spun column
containing silica gel-based membrane (RNeasy kit, QIAGEN). For Northern
blot analysis, 15 µg of total RNA/lane were fractionated on
agarose/formaldehyde gels. RNAs were transferred to a nylon charged
membrane (Hybond N+, Amersham Pharmacia Biotech) in 20×
SSC and hybridized with DNA probes. Loading of equal amounts of RNA in
each lane was assessed by ethidium bromide staining of ribosomal RNAs
upon UV illumination of the membrane and hybridization of the blots
with a -actin probe. Prehybridization and hybridization were
performed in 7% SDS, 1 mM EDTA, 0.5 M
Na2HPO4. A PCR fragment (1.2 kb) containing exons 2 and 3 from mCCR4 cDNA was used as a probe.
Hybridized blots were washed twice in 0.5× SSC, 0.1% SDS at 65 °C
for 15 min. Filters were then exposed for at least 3 days.
 |
RESULTS |
Murine and Human yCCR4-related cDNAs--
A 966-bp open
reading frame with similarity to the yeast CCR4 gene was
previously identified at the 3'-end of IAP LTR-initiated chimeric
transcripts (IAP-AR) resulting from a read-through into flanking
cellular sequences and detected exclusively in the liver of old mice
(12). These included a 10-kb transcript and two processed transcripts
of 6 and 3 kb (Fig. 1A). We
hypothesized this ORF to be part of the coding region of a putative
murine homologue, mCCR4, of the yeast CCR4 gene.
To characterize mCCR4-specific transcripts not initiated
within the IAP LTR but initiated, possibly, within the mCCR4
promoter, we used RNA from the brain as (i) no chimeric, IAP-promoted,
transcript had ever been detected in this organ (Ref. 16, and Fig.
1B), and (ii) this organ expresses a high level of
mCCR4-related transcripts (Fig. 1B and extensive analysis in Fig. 6). A pre-made Marathon-Ready brain cDNA library (CLONTECH) was therefore used for 5'- and 3'-RACE,
with primers designed based on the previously characterized ORF
sequence (see Fig. 1B for the strategy of cloning). 3'-RACE
PCR amplified a 1.5-kb fragment, which was found to contain the 3'-end
of the previously identified ORF and the same 1104-nt sequence as that of the 3' noncoding region of the IAP-AR chimeric cDNAs (including the same polyadenylation sequence). Characterization of the 5'-end of
the brain cDNAs proved to be particularly difficult, most probably because of the high G/C content of this region (see below). Actually, a
5'-RACE fragment that extended 200 bp 5' to the yCCR4-related ORF was
obtained, but larger fragments were recombinants most probably
generated by jumps of the reverse transcriptase in the cDNA library
construction. The complete characterization of the extreme 5'-end of
the cDNAs was finally rendered possible only by the cloning, and
direct sequencing, of the corresponding genomic region from a phage
library and the use, for 5'-RACE, of reverse primers designed from the
new 5' genomic sequence (see Fig. 1B and "Experimental
Procedures"). Two mCCR4 cDNAs, of 2628 and 3026 bp,
were finally characterized, which only differ by their transcription initiation sites (see also next sections). Their length is compatible with that of the two transcripts detected by Northern blot analysis (Fig. 1B), with a major transcript of 2.7 kb and a minor,
and not always visible, transcript of 3.1 kb. These two cDNAs
contain a single ORF of 1475 nt, that could encode a protein of 430 amino acids. A series of stop codons are present 185 bp upstream of the
first methionine codon, strongly suggesting that no longer protein can
be generated.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Structure of the murine yCCR4-related
transcripts and strategy for their characterization. A,
structure of previously characterized LTR-initiated IAP-CCR4 chimeric
transcripts and spliced derivatives (12). The IAP retrotransposon and
the ORF with similarity to yCCR4 are shown with the position of the
transcription start site in the 5'-LTR indicated by an
arrow. A Northern blot of transcripts from the liver
(Li) of aged mice is shown on the left, using the
indicated 966-bp CCR4 ORF probe for hybridization. The 10-, 6-, and
3-kb transcripts are indicated on the left and their
structure schematized on the diagram. B, non-IAP
CCR4-related gene transcripts from mouse brain (Br) and
strategy for cloning the corresponding cDNAs. A Northern blot is
shown on the left (same conditions as in panel
A). The sequences in common with the IAP-CCR4 chimeric transcripts
are schematized as in panel A, with the two initiation sites
indicated by arrows. Gene-specific primers (filled
triangles) used for RACE PCR, and PCR products obtained using each
of these primers together with the Marathon library adaptor-specific
primers (open triangles) are indicated.
|
|
We also looked for possible human homologues of these mCCR4
transcripts. Previous data base searches had revealed several human
expressed sequence tags that exhibited high levels of similarity to the
3'-region of the murine CCR4 and the Xenopus nocturnin cDNAs (10, 12). We therefore performed low-stringency PCR amplifications using a human pre-made Marathon-Ready placenta cDNA
library (CLONTECH), with one primer derived from
the T87026 human expressed sequence tag sequence and a second primer
derived from the murine CCR4 3'-coding regions to identify the 3'-part of the human homologue (exons 2 and 3). As previously observed for the
murine sequences, cloning of the cDNA 5'-region was rendered difficult by its high G/C content, at a position similar to that of the
murine gene. We performed several successive 5'-RACE PCRs using an
oligo(dT)-primed human cDNA library cloned into a retroviral vector,2 with primers derived from human and vector
sequences. We finally obtained a partial hCCR4 cDNA
sequence of 2397 bp. This cDNA contains a complete ORF of 1317 nt
that could encode a protein of 439 amino acids. The chromosomal
localization of this human sequence was further determined by the
Radiation Hybrid Mapping method (Genethon/Evry) using, for PCR
screening, oligonucleotides designed from the sequence of an intronic
region. The corresponding transcription unit was localized on
chromosome 4, close to the D4S1576-D4S1579 interval (LOD scores of
15.56 and 16.06, respectively). Interestingly, this locus is synthenic
with (i.e. contains a set of genes conserved in) the locus
containing the murine CCR4 gene (chromosome 3, B-D region;
see Ref. 12).
Amino Acid Conservation among yCCR4-related Proteins--
The
predicted amino acid coding regions of the human, murine,
Xenopus, and yeast proteins were compared, using the J. HEIN Multiple Sequence Alignment Program (Fig.
2). The Xenopus, murine, and
human proteins appear to lack the N-terminal region of yeast CCR4 (from
amino acids 1 to 432), which contains a leucine-rich repeat region
(amino acids 350-467) and two activation domains (6). Yet, they
display a significant similarity (close to 30%, including conservative
amino acid changes) with the yeast CCR4 protein within their C-terminal
domains, in a region corresponding to the second and third exons of the
Xenopus, murine, and human genes. High sequence similarity
(76% similarity) is also observed between the mammalian and
Xenopus proteins but again severely restricted to the region
corresponding to the second and third exons of the genes, the coding
region of the mammalian CCR4 first exons being significantly longer
(62/64 versus 22 amino acids) than, and divergent from, that
of Xenopus. Finally, the murine and human CCR4 proteins
display strong similarity (93%) equally distributed over the three
exons. This similarity stops immediately upstream of their respective
initiation codon, suggesting that these codons are those actually used
for initiation of translation.

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 2.
Comparison of the predicted amino acid
sequence of the human (hCCR4) and the murine (mCCR4) CCR4-related
proteins, of the Xenopus nocturnin, and of the yeast
CCR4 factor (yCCR4). Sequences are represented with the
single letter code, with numbers referring to amino acid
positions for each protein (GenBankTM accession numbers
U74761 and S50459 for nocturnin and yCCR4, respectively; and AF183960
and AF183961 for mCCR4 and hCCR4, respectively.). The first 21 N-terminal amino acids from nocturnin, as well as the 431 N-terminal
amino acids from yCCR4, could not be aligned with the mammalian
CCR4-related proteins. Dashes represent gaps introduced to
optimize alignment. Amino acid identities of the human CCR4 protein
with at least one of the three other proteins are boxed.
Positions corresponding to exon boundaries in mCCR4 are indicated. The
asterisk is positioned above the leucine residue of the
nocturnin leucine zipper-like motif not found in the murine and human
proteins.
|
|
A search for putative amino acid motifs in the sequence of mCCR4 (using
MOTIF finder) revealed several phosphorylation and glycosylation sites.
The leucine-rich repeat region present in the yCCR4 protein at position
350-467 (5) could not be found in the amino acid sequence of the
mammalian proteins. Moreover, although a consensus leucine zipper-like
motif was identified close to the N-terminal region of the putative
nocturnin protein (from 64 to 91; Ref. 10), no such motif could be
found in the human and mouse proteins, in particular because of the
absence of a leucine at position 125 and 123, respectively (indicated with a star in Fig. 2). Interestingly, search against a data base of
conserved blocks (19) revealed an 8-amino acid homology (PDILCLQEV, amino acids 186-194 in mCCR4) with a conserved motif involved in
Mg2+ or Mn2+ binding among the AP-
(Apurinic/Apyrimidinic) endonuclease family I (20). This motif is one
of the most conserved from yeast to human CCR4.
Genomic Organization of the Murine CCR4 Gene--
The genomic
organization of the murine mCCR4 gene was assessed by
different methods. Introns and locations of intron/exon boundaries were
identified by PCR reactions using a series of primers derived from the
sequence of the regions corresponding to the characterized cDNA. To
explore the 5' genomic region of the gene, a 129/sv mouse genomic
library (constructed with Sau3AI-restricted DNA) was
screened by a PCR-based method (see "Experimental Procedures"), and
the unique phage clone obtained was directly sequenced. It contained
part of intron 1 and 430 nt of exon 1, up to a Sau3AI site
in exon 1. More 5'-domains were characterized by inverted PCR using
genomic DNA, first restricted and then self-ligated, and divergent
primers derived from the newly identified sequences. As illustrated in
Fig. 3A, the mouse
mCCR4 gene spans almost 27 kb of genomic DNA, with three
exons and two introns (as previously observed, interestingly, for the
Xenopus nocturnin gene, see Ref. 10). Exon 1 contains 185 bp
of coding region. Intron1 is large (25 kb) and contains the IAP
insertion described in Ref. 12. The previously described ORF (12) is in
fact composed of exon 2 (268 bp) and exon 3 (that contains 836 bp of
coding sequence and 1.2 kb of 3'-untranslated region). In mouse genomic
DNA, these two exons are separated by 1.8 kb of intron 2 sequence.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
Genomic organization of the mCCR4
gene in common laboratory mouse strains. A,
genomic organization of the IAP-tagged mCCR4 gene in the
prototype DBA/2 mouse and of the IAP-free mCCR4 gene in the
CBA mouse. The exon-intron sequences are drawn to scale, with the
coding and untranslated regions represented with black and
gray boxes, respectively. The position of the IAP insertion
in the first intron of the gene is shown. Arrows indicate
the transcription start sites. Positions of the BglI
restriction sites (B) and of the probes (5' and 3') used for
gene mapping are indicated. B, distribution of inbred
laboratory and wild-type mouse strains according to the IAP insertion
within the mCCR4 gene. Presence of the IAP insertion was
determined by Southern blot analysis upon restriction of the DNA from
each mouse strain with BglI and hybridization with the
probes indicated in panel A. Lack of IAP insertion was
confirmed by PCR using primers bracketing the integration site.
C, characterization of the IAP insertion site: nucleotide
sequence of the IAP 5'- and 3'-ends and cellular flanking DNA in BALB/c
mice (top) and of the target site without IAP insertion in
CBA mice (bottom). IAP nucleotides are in uppercase
letters, cellular DNA sequence is in lowercase letters,
and the 6-bp target site duplication is delineated.
|
|
Surprisingly, genomic analysis of intron 1 revealed that the IAP
insertion is not common to all laboratory mouse strains. In a previous
paper (12), we had reported that the IAP-AR transcripts observed in the
liver of aged mice were induced in the four inbred strains tested,
i.e. C57BL/6, C57BL/10, BALB/c, and DBA/2. We have now
characterized eight inbred laboratory strains as well as two strains of
wild-type mice (PWK and SEG strains; gift from J. L. Guenet,
Pasteur Institute) for the presence of the IAP gene in intron 1, by
Southern blot analysis using probes flanking the IAP insertion (data
not shown). As indicated in Fig. 3B, the IAP insertion is
observed for DBA/2, C57BL/6, C57BL/10, Swiss, and BALB/c mice, whereas
no insertion could be detected for the C3H, SJL, CBA, and 129/sv mice,
as well as for the two wild-type mice. For the latter six mouse
strains, PCR reactions carried out with primers bracketing the IAP
target site yielded fragments of the expected size (730 bp). Sequencing
of these PCR fragments confirmed the absence of an IAP, and comparison
of the sequence (e.g. for the CBA mouse, Fig. 3C)
with the sequence flanking the IAP insertion in a BALB/c mouse revealed
a 6-bp duplication of the target sequence (see Fig. 3C), as
usually observed for IAP insertions (14). Altogether, these data show
that the germ-line transposition of the IAP into intron 1 occurred
recently, after the emergence of the laboratory strains,
i.e. less that 100 years ago. The high level of similarity
between the two IAP LTRs supports this conclusion.
Identification of a CpG Island at the 5'-End of the mCCR4 Gene and
Characterization of the mCCR4 Promoter--
The transcription start
sites of the murine mCCR4 gene were determined using 5'-RACE
PCR with reverse primers in exon 1 (Fig. 1B). Two major
bands were amplified and cloned. For each band, the 5'-end of several
products was sequenced and found identical, ending at the same
positions (Fig. 4A): the
smaller product revealed a first start site, defined hereafter as
position 1, located 110 bp upstream of the AUG codon and most probably
responsible for the major 2.7 kb transcript; and the other band
revealed a second start site, 400 bp upstream, possibly associated with
the fainter 3.1-kb transcript. Both transcription start sites are
included within a nucleotide sequence that fits moderately with the
transcription start site consensus YYAN(+1)(T/A)YY (21, 22).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 4.
Characteristic features of the 5'-domain of
the mCCR4 gene. A, nucleotide sequence of
the mCCR4 promoter region (GenBankTM accession number
AF183962). The two transcription start sites (arrows) and
the corresponding transcription initiator sequences (init)
are indicated. The ATG start codon is boxed. The sequences
of potential binding sites for the Sp1 and NF- B factors are
underlined. B, distribution of CpG and GpC dinucleotides in
the 5' genomic region of mCCR4. The indicated CpG island is
defined according to the criteria in Ref. 23 as a region with a
percentage of G+C >50 and a CpG/GpC ratio >0.6. Exon 1 with the
untranslated (shaded) and translated (black)
regions is boxed, non-exonic regions are drawn as a
line, and the two transcription start sites are positioned
with arrows.
|
|
Analysis of the genomic sequences encompassing the 5'-end of the murine
mCCR4 gene discloses a CpG island, a marker of promoter regions of the so-called "housekeeping," or ubiquitously expressed, genes (although some tissue-specific genes also have these
characteristic features, Ref. 23). This region extends from nt 413 to
+525 (Fig. 4B), has a high G/C content (% G+C = 0.72)
and an observed overexpected CpG/GpC ratio of 1.1 (mean genome value
0.2; see Ref. 23). Moreover, screening of the 540 to +400 region for putative transcription factor binding sites (using the TRANSFAC program), revealed features common to CpG island-containing promoters (23): two GC boxes, which are potential Sp1 binding sites, can be
identified 110 bp upstream of the major transcription start site (Fig.
4A), whereas neither a TATA- nor a CAAT-box motif is present. Interestingly, a putative binding site for NF- B can be
found at position 220.
To determine whether the 5'-end of the mCCR4 gene possesses
a promoter activity and to identify important regulatory domains, 5'-deletion fragments of this region (with a fixed 3'-end at position +114) were generated through restriction endonuclease digestion and
cloned in the sense or antisense orientation upstream of a luciferase
reporter gene (Fig. 5A). These
constructs, as well as a promoterless luciferase vector and an SV40
promoter/enhancer luciferase vector as controls, were introduced by
transfection into 3T3 cells (which express the endogenous
mCCR4 gene).3 As
shown in Fig. 5B, the 600-bp fragment spanning nt 500 to +114 of the putative promoter induces a 200-fold increase in luciferase activity as compared with the control promoterless basic vector. Deletion to nt 227 (thus eliminating the first initiator signal) results in only a 2-fold reduction in promoter activity. Deletion to nt
100, removing the putative Sp1 and NF- B sites, results in a
dramatic (more than 30-fold) reduction in promoter activity. Surprisingly, further deletion to position 30 restored the
transcriptional activity up to 50-fold that of the promoterless control
vector, suggesting that a repressive element might reside in this
region. Finally, further deletion to position +4 dramatically abolished promoter activity, most probably as a result of the deletion of the
initiator site. This analysis therefore provides evidence that the
region between nt 500 and +4, encompassing the two transcriptional initiation sites, possesses elements with positive and negative effects
on transcription, and that the most proximal sequences, between nt 30
and +114 are sufficient for promoter activity. Several CpG
island-containing genes have promoters that can initiate transcription
in both orientations (24-26). The same fragments as above were
therefore tested for their ability to promote transcription in the
reverse orientation. As shown in Fig. 5B, all fragments tested initiate transcription almost as efficiently as the
corresponding fragments in the sense orientation, thus clearly
demonstrating that the mCCR4 promoter can direct initiation
bidirectionally. Interestingly, this transcriptional activity in
reverse orientation requires the minimal +114/+4 domain, as evidenced
by the ability of this fragment to promote an 80-fold increase in
luciferase activity as compared with the promoterless control vector.
This fragment initiates transcription efficiently in the reverse and not in the normal orientation, most probably because the initiator element, which is deleted in this fragment and is essential for transcription in the normal orientation, is not part of the reverse promoter.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Promoter activity of the mCCR4
gene. A, schematic drawing of the 5'-region of
mCCR4 and of the luciferase reporter genes used in the
transient transfection assays. The restriction sites used for
construction of the indicated luciferase (luc) reporter
genes and their position relative to the first transcription start site
are given. Putative Sp1 and NF- B binding sites are positioned. The
mCCR4 fragments were cloned into the pGL3 expression vector,
either in the sense or antisense orientation (as schematized by
arrows). The SV40 promoter-enhancer vector (SV pGL3) and the
promoterless pGL3 vector were used as positive and negative controls,
respectively. B, promoter activities of the reporter genes
in NIH-3T3 cells. Cells were transfected with the indicated reporter
genes together with the lacZ-containing CMV plasmid (Stratagene) to
normalize for transfection efficiency. Luciferase and -galactosidase
activities were measured 2-days post-transfection. Values are the means
of at least two independent experiments, each performed in
duplicate.
|
|
In Vivo Expression of the Murine mCCR4 Gene--
To get insight
into the putative function of the mCCR4 gene, we analyzed
its pattern of expression in several mouse organs. For each organ, mice
of a strain with (DBA/2) or without (CBA) the IAP insertion were
compared. Total RNAs were extracted and analyzed by Northern blot,
using as a probe a 1-kb fragment encompassing exons 2 and 3 of the
mCCR4 gene (Fig. 1). As illustrated in Fig. 6, and as expected for a
"housekeeping" gene, mCCR4 transcripts are observed in
all the organs tested, although at a variable level. Interestingly,
comparison of this pattern in both strains (the one with the IAP
insertion in intron 1 and the one without) reveals no difference,
neither in the size nor in the relative abundance of the transcripts
from one organ to another, therefore suggesting that the insertion of
the IAP is neutral for transcription of the mCCR4 gene. One
major exception, as previously reported, concerns transcription in the
liver of aged mice where IAP LTR-initiated chimeric transcripts
extending through the mCCR4 exons 2 and 3 are induced at a
high level. Finally, it is worth mentioning that expression of
mCCR4 is high in the retina, as well as in the brain, both
organs known to be involved in the circadian clock in mammals (27,
28).

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 6.
Pattern of expression of the murine
mCCR4 gene in several organs from DBA/2 and CBA mice.
DBA/2 mice have the IAP insertion in the mCCR4 first intron
(+) but not the CBA mice ( ). 15 µg of total RNA from the indicated
organs (except for the retina in lane ret*, 4 µg) were
analyzed on Northern blots using the mCCR4 probe indicated in Fig.
1A. Mice were 2-3 month old, except for lanes
liver°, loaded with RNA from the liver of 2-year old mice.
|
|
 |
DISCUSSION |
A Protein with Similarities to the Yeast CCR4 General Transcription
Factor, Conserved among Vertebrates--
In this report, we have
identified, for the first time in mammals, genes related to the yeast
gene encoding the yCCR4 general transcription factor. The murine and
human genes are located on synthenic chromosomal loci and encode
putative proteins disclosing high levels of identity. Furthermore, the
murine and human yCCR4-related gene products are closely related to a
Xenopus yCCR4-related protein, named nocturnin (10). The
region of similarity corresponds to the almost complete sequence of the
vertebrate proteins, but only to the C-terminal half of the yeast
factor, which is twice as long as the vertebrate proteins. This region
was previously demonstrated to be necessary but not sufficient alone
for transcriptional activation by yCCR4 (6), but its exact function in
yeast has not been elucidated. The two N-terminal activation domains
and the leucine-rich repeats described in yCCR4 are absent from the
vertebrates proteins. No other such leucine-rich tandem repeats could
be found in the amino acid sequence of the mammalian proteins.
Similarly, the consensus leucine zipper-like motif described near the
N-terminal region of the nocturnin protein, from amino acids 64-91
(10), is not found in the human and mouse proteins. Although the
presence of a zipper motif in nocturnin but not in the murine and human yCCR4-related proteins is conceivable, the occurrence of a proline residue, incompatible with an -helical secondary structure, in the
zipper region of nocturnin (as noted by the authors themselves) casts
some doubt on the existence of such a functional motif in nocturnin as
well. Finally, based on a previous characterization of the 3'-end of
the murine yCCR4-related gene by both Southern blot analysis and
chromosome in situ hybridization (12), it is very likely
that at least the murine gene is a single copy gene. Accordingly, the
observed difference in the length of the vertebrate CCR4-related
proteins and the yeast CCR4 factor most probably reflects an evolution
from a multiple domain transcription factor of large size, as observed
for yCCR4, to the smaller vertebrate CCR4-related factors, which only
contain part of the functional domains of yCCR4. It is conceivable that
the N-terminal part of yCCR4, not found in the CCR4-related vertebrate
proteins, participates in a multi-component vertebrate transcription
complex as a separate protein element. Such an evolutionary
"splitting" of the yCCR4 factor might have favored more complex
regulations to take place within the CCR4 transcription complex.
Possible Functions of the Murine yCCR4-related Gene--
Analyses
of the sequence and pattern of expression of mCCR4 have
revealed characteristic features of most "housekeeping" genes: the
mCCR4 promoter contains a CpG island (high G/C content and CpG/GpC value, Sp1 binding sites, absence of a TATA box), and the gene
is ubiquitously expressed in most mouse tissues. As such, mCCR4 is likely to be involved in essential cellular
processes. Deletion analyses have revealed that the putative Sp1 and
NF- B binding sites within the promoter sequence are important for
gene activity as well as other domains, although not containing easily recognizable binding sites, which disclose either positive or negative
effects. Yet, the physiological relevance of these cis-regulatory sequences remains to be demonstrated in vivo. Finally, we
have shown that the mCCR4 promoter directs transcription in
both orientations. This might suggest the existence of an upstream
divergent gene sharing a bidirectional promoter with the
mCCR4 gene, a feature common to other CpG island-containing
housekeeping genes (24-26).
The nocturnin yCCR4-related gene was previously demonstrated to exhibit
rhythmic expression in Xenopus retina, and therefore to
function as a clock-controlled gene or a component of the clock itself
(10). Although we have not been able to obtain evidence for such a
circadian-regulated expression of mCCR4 in the murine retina, it remains plausible that mCCR4 is involved in a circadian regulation. Actually, in mammals the circadian clock resides primarily in the suprachiasmatic nucleus of the hypothalamus and not in the
retina (Refs. 27 and 29; but see also Ref. 28), and it is also known
that clock orthologs within different species share extensive
structural features but are subjected to different regulatory schemes.
For instance, the Drosophila clock and
tim transcripts show daily rhythm, whereas their murine
orthologs do not oscillate (30-33). Accordingly, mCCR4
which is highly expressed both in the retina and the brain could have a
function in the circadian clock, as shown for nocturnin, but not be
rhythmically regulated. It is also worth mentioning that many
clock-regulated genes are housekeeping genes.
Consequences of IAP Insertion in the Intron of the mCCR4
Gene--
There are several examples where IAP sequences have
disrupted gene expression as a consequence of their insertion into an intron (34-36), either by interfering with transcription or by destabilizing the message. In addition, aberrant chimeric transcripts from a targeted gene, involving splice sites within IAP sequences, are
frequently observed (37). Rather unexpectedly, the insertion of an IAP
sequence within the first intron of the mCCR4 gene appears to be neutral with regard to transcription of mCCR4. Indeed, sequencing of the two mCCR4 transcripts revealed no alternative
splicing involving some IAP site, and Northern blot analyses using
mouse strains with or without IAP insertion have failed to detect any differences in the size of the transcripts (that could have suggested exon skipping and/or transcription termination) and in the pattern of
expression of mCCR4 between the two mouse strains.
Transcriptional read-through previously described for the LTR-initiated
IAP-CCR4 chimeric transcripts in the liver of old mice has led us to
postulate the existence of mechanisms abolishing the polyadenylation
efficiency of the 3'-LTR of the inserted IAP element (12). It is likely that the same mechanism accounts for the absence of transcription termination within the IAP 3'-LTR of the mCCR4-promoted
transcripts in all organs tested. The molecular mechanisms responsible
for the occurrence of this read-through might involve, as observed in
Drosophila for genes mutated by retrotransposon insertion
(e.g. wapricot mutation, Ref. 38), suppressors
of transcription termination, which still remain to be identified in
mammals. Whatever the underlying molecular mechanisms, the strong
selective pressure that preserved mCCR4 from the deleterious
effect of IAP insertion suggests an important role for this factor in
mammals. Transgenesis experiments with a mutated gene most probably
will be necessary to unravel the role of mCCR4 in the mouse, as well as
genetic analyses of the corresponding chromosomal locus in humans.
 |
ACKNOWLEDGEMENTS |
We thank G. Hamard (U129, Paris) for
providing us with the 129/sv mouse genomic library, J. L. Guenet
(Institut Pasteur, Paris) for the PWK and SEG mice, and Y. Courtois
and J. C. Jeanny (U450, Paris) for help with the retina experiments. J. Weissenbach and G. Gyapay (Genethon, Evry) are especially acknowledged
for the localization of the human CCR4-related gene, and L. Corbo and D. Prévôt (U453, Lyon) are acknowledged for helpful
discussions and suggestions and for communication of unpublished results.
 |
FOOTNOTES |
*
This work was supported by grants from the Association pour
la Recherche sur le Cancer.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF183960, AF183961, and AF183962.
To whom correspondence should be addressed. Tel.:
33/1-42-11-49-70; Fax: 33/1-42-11-53-42; E-mail:
heidmann@igr.fr.
2
T. Tchénio and T. Heidmann, manuscript in preparation.
3
W. Barbot, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
kb, kilobase(s);
ORF, open reading frame;
IAP, intracisternal A-particle;
LTR, long
terminal repeat;
RACE, rapid amplification of cDNA ends;
PCR, polymerase chain reaction;
UTR, untranslated region;
bp, base pair(s);
nt, nucleotides.
 |
REFERENCES |
| 1.
|
Denis, C. L.
(1984)
Genetics
108,
833-843[Abstract/Free Full Text]
|
| 2.
|
Denis, C. L.,
and Malvar, T.
(1990)
Genetics
124,
283-291[Abstract]
|
| 3.
|
Liu, H.-Y.,
Toyn, J. H.,
Chiang, Y.-C.,
Draper, M. P.,
Johnson, L. H.,
and Denis, C. L.
(1997)
EMBO J.
16,
5289-5298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Liu, H.-Y.,
Badarinarayana, V.,
Audino, D. C.,
Rappsilber, J.,
Mann, M.,
and Denis, C. L.
(1998)
EMBO J.
17,
1096-1106[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Malvar, T.,
Biron, R. W.,
Kaback, D. B.,
and Denis, C. L.
(1992)
Genetics
132,
951-962[Abstract]
|
| 6.
|
Draper, M. P.,
Liu, H.-Y.,
Nelsbach, A. H.,
Mosley, S. P.,
and Denis, C. L.
(1994)
Mol. Cell. Biol.
14,
4522-4531[Abstract/Free Full Text]
|
| 7.
|
Verdone, L.,
Cesari, F.,
Denis, C. L.,
Di Mauro, E.,
and Caserta, M.
(1997)
J. Biol. Chem.
272,
30828-30834[Abstract/Free Full Text]
|
| 8.
|
Schild, D.
(1995)
Genetics
140,
115-127[Abstract]
|
| 9.
|
McKenzie, E. A.,
Kent, N. A.,
Dowell, S. J.,
Moreno, F.,
Bird, L. E.,
and Mellor, J.
(1993)
Mol. Gen. Genet.
240,
374-386[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Green, C. B.,
and Besharse, J. C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
14884-14888[Abstract/Free Full Text]
|
| 11.
|
Draper, M. P.,
Salvadore, C.,
and Denis, C. L.
(1995)
Mol. Cell. Biol.
15,
3487-3495[Abstract]
|
| 12.
|
Puech, A.,
Dupressoir, A.,
Loireau, M.-P.,
Mattei, M.-G.,
and Heidmann, T.
(1997)
J. Biol. Chem.
272,
5995-6003[Abstract/Free Full Text]
|
| 13.
|
Kuff, E. L.,
and Lueders, K. K.
(1988)
Adv. Cancer Res.
51,
183-276[Medline]
[Order article via Infotrieve]
|
| 14.
|
Heidmann, O.,
and Heidmann, T.
(1991)
Cell
64,
159-170[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Kuff, E. L.
(1990)
Cancer Cells
2,
398-400[Medline]
[Order article via Infotrieve]
|
| 16.
|
Dupressoir, A.,
Puech, A.,
and Heidmann, T.
(1995)
Biochim. Biophys. Acta
1264,
397-402[Medline]
[Order article via Infotrieve]
|
| 17.
|
Israel, D. I.
(1993)
Nucleic Acids Res.
21,
2627-2631[Abstract/Free Full Text]
|
| 18.
|
Dupressoir, A.,
and Heidmann, T.
(1996)
Mol. Cell. Biol.
16,
4495-4503[Abstract]
|
| 19.
|
Henikoff, S.,
and Henikoff, J. G.
(1994)
Genomics
19,
97-107[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Seki, S.,
Ikeda, S.,
Watanabe, S.,
Hatsushika, M.,
Tsutsui, K.,
Akiyama, K.,
and Zhang, B.
(1991)
Biochim. Biophys. Acta
1079,
57-64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Smale, S. T.,
and Baltimore, D.
(1989)
Cell
57,
103-113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Bucher, P.
(1990)
J. Mol. Biol.
212,
563-578[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Gardiner-Garden, M.,
and Frommer, M.
(1987)
J. Mol. Biol.
196,
261-282[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Liao, W.-C.,
Ash, J.,
and Johnson, L. F.
(1994)
Nucleic Acids Res.
22,
4044-4049[Abstract/Free Full Text]
|
| 25.
|
Schilling, L. J.,
and Farnham, P. J.
(1995)
Cell Growth Differ.
6,
541-548[Abstract]
|
| 26.
|
Qvist, H.,
Sjöström, H.,
and Norén, O.
(1998)
Biol. Chem.
379,
75-81[Medline]
[Order article via Infotrieve]
|
| 27.
|
Ralph, M. R.,
Foster, R. G.,
Davis, F. C.,
and Menaker, M.
(1990)
Science
247,
975-978[Abstract/Free Full Text]
|
| 28.
|
Tosini, G.,
and Menaker, M.
(1996)
Science
272,
419-421[Abstract]
|
| 29.
|
Welsh, D. K.,
Logothetis, D. E.,
Meister, M.,
and Reppert, S. M.
(1995)
Neuron
14,
697-706[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Sun, Z. S.,
Albrecht, U.,
Zhuchenko, O.,
Bailey, J.,
Eichele, G.,
and Lee, C. C.
(1997)
Cell
90,
1003-1011[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Bae, K.,
Lee, C.,
Sidote, D.,
Chuang, K.,
and Edery, I.
(1998)
Mol. Cell. Biol.
18,
6142-6151[Abstract/Free Full Text]
|
| 32.
|
Sangoram, A. M.,
Saez, L.,
Antoch, M. P.,
Gekakis, N.,
Staknis, D.,
Whiteley, A.,
Fruechte, E. M.,
Vitaterna, M. H.,
Shimomura, K.,
King, D. P.,
Young, M. W.,
Weitz, C. J.,
and Takahashi, J. S.
(1998)
Neuron
21,
1101-1113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Zylka, M. J.,
Shearman, L. P.,
Levine, J. D.,
Jin, X.,
Weaver, D. R.,
and Reppert, S. M.
(1998)
Neuron
21,
1115-1122[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Xiao, G.-H.,
Jin, F.,
and Yeung, R. S.
(1995)
Oncogene
11,
81-87[Medline]
[Order article via Infotrieve]
|
| 35.
|
Hamilton, B. A.,
Smith, D. J.,
Mueller, K. L.,
Kerrebrock, A. W.,
Bronson, R. T.,
van Berkel, V.,
Daly, M. J.,
Kruglyak, L.,
Pat Reeve, M.,
Nemhauser, J. L.,
Hawkins, T. L.,
Rubin, E. M.,
and Lander, E. S.
(1997)
Neuron
18,
711-722[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Gwynn, B.,
Lueders, K.,
Sands, M. S.,
and Birkenmeier, E. H.
(1998)
Mol. Cell. Biol.
18,
6474-6481[Abstract/Free Full Text]
|
| 37.
|
Vasicek, T. J.,
Zeng, L.,
Guan, X.-J.,
Zhang, T.,
Costantini, F.,
and Tilghman, S. M.
(1997)
Genetics
147,
777-786[Abstract]
|
| 38.
|
Zachar, Z.,
Davison, D.,
Garza, D.,
and Bingham, P. M.
(1985)
Genetics
111,
495-515[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Ohn, Y.-C. Chiang, D. J. Lee, G. Yao, C. Zhang, and C. L. Denis
CAF1 plays an important role in mRNA deadenylation separate from its contact to CCR4
Nucleic Acids Res.,
May 14, 2007;
35(9):
3002 - 3015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Garbarino-Pico, S. Niu, M. D. Rollag, C. A. Strayer, J. C. Besharse, and C. B. Green
Immediate early response of the circadian polyA ribonuclease nocturnin to two extracellular stimuli
RNA,
May 1, 2007;
13(5):
745 - 755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Garbarino-Pico and C. B. Green
Posttranscriptional Regulation of Mammalian Circadian Clock Output
Cold Spring Harb Symp Quant Biol,
January 1, 2007;
72(0):
145 - 156.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Banno, K. Kaminaka, K. Soejima, K. Kokame, and T. Miyata
Identification of Strain-specific Variants of Mouse Adamts13 Gene Encoding von Willebrand Factor-cleaving Protease
J. Biol. Chem.,
July 16, 2004;
279(29):
30896 - 30903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Uchida, S.-i. Hoshino, and T. Katada
Identification of a Human Cytoplasmic Poly(A) Nuclease Complex Stimulated by Poly(A)-binding Protein
J. Biol. Chem.,
January 9, 2004;
279(2):
1383 - 1391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Decker and R. Parker
mRNA decay enzymes: Decappers conserved between yeast and mammals
PNAS,
October 1, 2002;
99(20):
12512 - 12514.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Barbot, A. Dupressoir, V. Lazar, and T. Heidmann
Epigenetic regulation of an IAP retrotransposon in the aging mouse: progressive demethylation and de-silencing of the element by its repetitive induction
Nucleic Acids Res.,
June 1, 2002;
30(11):
2365 - 2373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pype, W. Declercq, A. Ibrahimi, C. Michiels, J. G. I. Van Rietschoten, N. Dewulf, M. de Boer, P. Vandenabeele, D. Huylebroeck, and J. E. Remacle
TTRAP, a Novel Protein That Associates with CD40, Tumor Necrosis Factor (TNF) Receptor-75 and TNF Receptor-associated Factors (TRAFs), and That Inhibits Nuclear Factor-kappa B Activation
J. Biol. Chem.,
June 9, 2000;
275(24):
18586 - 18593.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|